← Back to Clinical Trials
Recruiting NCT07349550

NCT07349550 AtWork: The Relation Between Cognitive Functioning, Common Mental Disorders and Work Functioning

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07349550
Status Recruiting
Phase
Sponsor Norwegian University of Science and Technology
Condition Depression - Major Depressive Disorder
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2024-01-01
Primary Completion 2029-08-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2024-01-01 with a primary completion date of 2029-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Depression and anxiety affects levels of function across different levels like work, increasing levels of sick leave and as well as cognitive functioning. In the current study patients at risk of sick leave with depression and anxiety receive metacognitive therapy and work focus in an ordinary outpatient clinic. Impaired cognitive functioning may also be of importance in the return to work process and degree of sick leave. It is important to get a better understanding of how cognitive functioning is related to sick leave and if it predicts return to work, and if cognitive functioning is changed due to psychological treatment.

Eligibility Criteria

Inclusion Criteria: * diagnosis of depression and/or anxiety, * at risk of sick leave Exclusion Criteria: * personality disorders cluster A or B, * ongoing substance abuse, * symptoms of psychosis, * acute suicidality, * serious somatic disorders

Contact & Investigator

Central Contact

Odin Hjemdal, PhD

✉ odin.hjemdal@ntnu.no

📞 +4773597889

Frequently Asked Questions

Who can join the NCT07349550 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Depression - Major Depressive Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07349550 currently recruiting?

Yes, NCT07349550 is actively recruiting participants. Contact the research team at odin.hjemdal@ntnu.no for enrollment information.

Where is the NCT07349550 trial being conducted?

This trial is being conducted at Oslo, Norway.

Who is sponsoring the NCT07349550 clinical trial?

NCT07349550 is sponsored by Norwegian University of Science and Technology. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology